title: Captopril-triggered linear IgA bullous dermatosis.
authors.affiliation: George Washington University School of Medicine, Washington, DC, USA.
authors.forename: I S
authors.initials: IS
authors.lastname: Friedman
authors.forename: D
authors.initials: D
authors.lastname: Rudikoff
authors.forename: R G
authors.initials: RG
authors.lastname: Phelps
authors.forename: A N
authors.initials: AN
authors.lastname: Sapadin
mesh_terms: D001323:Autoantibodies / Q000276:immunology*; D001485:Basement Membrane / Q000276:immunology / Q000473:pathology; D002216:Captopril / Q000009:adverse effects*; D003622:Dapsone / Q000627:therapeutic use; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology
chemical_list: D001323:Autoantibodies; D007070:Immunoglobulin A; D003622:Dapsone; D002216:Captopril; D011241:Prednisone